Jianqing Lin

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo et al. · Journal of Clinical Oncology · 2014 · 278 citations · Full text

The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.

Jianqing Lin, Rosalyn M. Adam, Eric Santiestevan et al. · PubMed · 1999 · 242 citations

Chemoprevention Strategy, Apoptosis, Cell Death +17

Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

Jianqing Lin, Michael C. Haffner, Yonggang Zhang et al. · The Prostate · 2010 · 192 citations · Full text

Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor

Sushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al. · PLoS ONE · 2010 · 152 citations · Full text